WeightWatchers recently announced a $132 million deal to acquire telehealth company Sequence and enter the prescription drug space (think: GLP-1 drugs like Wegovy and Ozempic). It begs the question: why is a company built on personal accountability facilitating medical interventions? We ask our guest, WeightWatchers CEO Sima Sistani. Before and after the int ... Show More
Yesterday
Create or Destroy: Reimagining Marketing with Seth Matlins
Today, we’re bringing you an episode of “Create or Destroy: Reimagining Marketing with Seth Matlins,” a new podcast from the Vox Media Podcast Network. In this episode, host and marketer Seth Matlins speaks with political strategist David Axelrod, who was President Obama’s chief ... Show More
54m 2s
Jun 15
Peter Chernin on ‘Backrooms,’ Sequel Fatigue, and Hollywood Mergers
The low-budget horror film ‘Backrooms’ is the surprise hit of the summer so far, netting more than $200 million globally in its leap from YouTube to the big screen. But among the film’s producers is a Hollywood heavyweight: Peter Chernin. As the former president and COO of News C ... Show More
1h 1m
Feb 2024
The Big Business Behind Weight Loss Drugs
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ... Show More
33m 54s
Oct 2023
Semaglutide: Decoding the hype around the weight loss wonder drug
<p>From Elon Musk to several Hollywood celebrities, the weight loss wonder drug, semaglutide, is taking the world by storm. What was an unintended consequence of a diabetes control med, the emergence of significant weight loss has raised the expectation of the wonder drug becomin ... Show More
32m 7s
